CD24 and triple-negative breast carcinoma: Interestingly, inhibition of Cdk2 kinase activity selectively targets and restores the chemosensitivity of SUM149PT in a CD44+/CD24-/Low stem-like subpopulation of triple-negative breast cancer cells [45].